{"name":"Kintara Therapeutics, Inc.","slug":"kintara-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPTmhxaDdQVGplazVBRVYzV2tlVHVTUGVEdlN2WmtLd1dCclBJREVfbU5Sby1qRVQyZGVnMFAzRWJha3p4RGlXRjRYYWx0NHU2S2k5aV9CWjVoanRRcWV2QzZFcHFTX3hJWEI0b3VSSDBSQlQ2VU9FazdzbDBVeEZyLXUxYzVSdFk1RnFsVXM3VUE4RmJaV2FXME1XczBuaS1PRERlMzlicWF1MWp6ZEllQ3NLd0JZMHB4MXN2aGtaVm5iMk5WRXVDOTJZeVRTVElNNUpBLWd2T0NVb2Z5M1dRMmF5aXZWTkFZNTU1NVV3dVdKRUpOS3FSMG1pS3B4UkZRR0FERUJQbndLeno3WTlJTmtEWC1mNVdsXzNCQ25aUzFlUU5lU01jV2F3VVVNYjVMcnh3VDJpUzRrclQ5?oc=5","date":"2025-12-04","type":"regulatory","source":"prnewswire.com","summary":"Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approvals and Expanding Patient Pool | DelveInsight - prnewswire.com","headline":"Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approva","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNOWpYeU5zaFZNaUR3QTNtN0FNemc1M0dORmt2VW52QWplYktBdW9mVjdtSms4azhNaUhIdGNWVFVQSnEzLUhwMFRTZUZac045dnhqaHRXMFJjVkJiMzlKV0xoaFRhQURYMkstRXlMcHpLdnFXZzEtRl9idGlYME5lTU9QTWZ4NXZRZVktb0N2SkdHUVptNG1XdzNJbGhOWElqTERXNw?oc=5","date":"2025-05-06","type":"pipeline","source":"CytoDyn Inc.","summary":"CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer - CytoDyn Inc.","headline":"CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wJBVV95cUxOZmpGMnRsalMzenhKOGw2YzVHdVI2UkcxLWJnQXNnSWRjN0VZZFV3b2F4VFVDTWZESnJGLW9RLUxsUzZ2bWhYTUxTUTM3c1dTZ0JCMUtxcDBPWnJpU3Q5Z3hua2MxNG1tMlVPRTlDTFQzTm1FaEs1MFRfbnJkaW9pT1RSNlhla2lRN0xSVFNyZDU2Y20xTml0dGx0a1E5RlcwakZPN3dUaUJPTUhTV1NoMlBxTXBWZWJlNzFMbWFzVmVyeEVQb0h2dXczMm1hUHk0MDhpVUJtak1mS1dlYnBEcnRhY3VpR3IxaFNuZTh0MEdDbFF5a0dlUXhweDlFbDhjQ3lzOFh0akRqdDUtLWdxMV9sTDBZQkMycUpIdkhyVG9JWG05cVA5Q1JPNlFxMEp1R0RhTmF1UDRXZ0NNV0pvWUJBa3hJQjFzUGdqZkhYQkt2b1NDS1Y3UDdTaTdFWUE?oc=5","date":"2024-10-18","type":"deal","source":"prnewswire.com","summary":"Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 - prnewswire","headline":"Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPMkNFOVFBSlNXVmFQRlFCeEhCQnFDSDZBQWI4UHVhTWp4bXJEWXNVcVVDYUtVaDFRd0QyVXpvZTVueF9OQWNsYUYzTGxwVzk4N19FZUtJWTdjZ1AtQ3pHcWJMX1prdmJpTGxnU3I3Z3RNV05VMjRnSnhncDUxc19KS2FKaW9WZUJQZFQ3R3c0NzhRdGRJdGRIaFBneC0wTVZaVkhHRGo0LXhTdlkzMGVJbkRrSW5aQjZGRHlYbVhoQldFVWlrNGo5d3hid2RtTjFGM0hfMDRkZGxCeEJRZ3gxVFNnRGJXdzNjenRhUkNqeDJ2UzQ3N0NTNmFoUjRqbzE4ZmJackpHZXNwZw?oc=5","date":"2024-10-16","type":"deal","source":"prnewswire.com","summary":"Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - prnewswire.com","headline":"Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Bioscienc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNTFJsNmo3VzUwcW1fMmhLRVROb1FQYnNXcGZFQWg2M3dCeVZYdGpYSzFFWkdfbFVNNDg2MEhEV2I5TFBWUC0zdEFHd3BkMW5qU0FsRWZpWWRjcjB4elVXTl9KNTQ4QV9xNk5jQ2c3Y3hFcnF4TFZERUJXWERNamtvLXljQ2tZNy1raGZxcWZ1NEVoVmZtbm8zWEhQWk5KbVNWRzFpQlBxVC1aRkxEeFVBNHRZUmhsN0RxZXc3QTRWdTBCTDhtQ0RlMWdTMXhGQU0wSGRDQjRVQXo3UnI4dVZN?oc=5","date":"2024-10-08","type":"earnings","source":"prnewswire.com","summary":"Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update - prnewswire.com","headline":"Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQa1VvUEdrRWdUXzVGSmxBMzVmUE9ZcFBNV25sNVZuUVBLUGxXaUVzR1VPdTRIQk5xcWp5SjRicnRrNGFDVklacE1MeVFyZmJaMmhPeUthX3dIZjlhcWJVX001ZkVJLXNJVmZPSXdzQ0JiWll2b2pFMGpsOE01VjFjNi16VVJfd0FXYTNfVEQxOWNLdFBFQ1BUUnhOem1maDg4Nk15bFVDM0pVZ0RDZ1Z1U2NQcjgtVHoyRldydEpfSlZNa0IxMlp0blBR?oc=5","date":"2024-05-14","type":"earnings","source":"prnewswire.com","summary":"Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results - prnewswire.com","headline":"Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOWGZOd0RQYXpTbkRrMjZmanB1U0ROd3Q4Mkt5MldMMnE2QkNrMFJEMGhyZ3FqV1hqS2V0WFRjMnc5MjI3TG1WaTFwdnE4YVYyQTFuRnNpd2haa0trMzdubU9iSkNDUFhEUFcxTG0xdTRPUVBVbXlpa21OQUdJeFlfYlgtc294OEV1MmRzR3Fud3djamR0eWNoRXlpNWN3dHc?oc=5","date":"2024-04-03","type":"pipeline","source":"Contract Pharma","summary":"Kintara Therapeutics and TuHURA Biosciences to Merge - Contract Pharma","headline":"Kintara Therapeutics and TuHURA Biosciences to Merge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiR0FVX3lxTE1uT2poNWE4X1V4X3RkSlJPcFNKSHV6TkdhYU9QVDI2Q3IzZW5ReFAyMWRUTm9zZXBiVHpGVnJsM18xdVc5T3VZ?oc=5","date":"2022-08-19","type":"pipeline","source":"StockInvest.us","summary":"KTRA - Kintara Therapeutics Inc. Company Profile - StockInvest.us","headline":"KTRA - Kintara Therapeutics Inc. Company Profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNYUFKbkd1ZEt6TmVfWk9PaUMzYnR4cFhNeWpZSFlKb0dQcUZtMmxOQUlRWURFUzFWeWVxOVVhWThGWER4dkZvRklPVUh2T2pQUnI1eDhWT3g3RW9ldFVMM2JtMnBvblhlaTlyTEZyLUJPUFFVZHdnSEdYTG5XZ0FMZjRtV2VLaGRlQUdyZE1FbWJXWDg2YlFEaU5qTmVwajZ2ckJqdEdQZExPMkZXanVKeG54dW4zd0VfaHRxVlREZHctcnlSVUtLQ2hVQlVJNVV4NEhXazl2dGNoNU5EamNyY3ZvYkJGbHdKWVRHeTNiYmdvRDRDX1J5dHRkd0xNbWVWRldBWXl0MkE2X1R1VU44Qg?oc=5","date":"2021-09-28","type":"pipeline","source":"proactiveinvestors.com","summary":"NA Proactive news snapshot: Argentina Lithium & Energy, Manganese X, Trust Stamp, Kintara Therapeutics, O3 Mining UPDATE .... - proactiveinvestors.com","headline":"NA Proactive news snapshot: Argentina Lithium & Energy, Manganese X, Trust Stamp, Kintara Therapeutics, O3 Mining UPDATE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA3QUotbXBKa0hjZFJRQ0dTaGtVTTY3VzRqUHU2bGZSX09DMFdYVmplbWdxTE9PXzBvVFc3UmRqM2NQUHhWMEhKb3BscTNMdXRPcmI5MHBRMDNkcG5zUEZ3?oc=5","date":"2020-10-05","type":"pipeline","source":"ChartMill","summary":"KTRA Stock Price, Quote & Chart | KINTARA THERAPEUTICS INC (NASDAQ:KTRA) - ChartMill","headline":"KTRA Stock Price, Quote & Chart | KINTARA THERAPEUTICS INC (NASDAQ:KTRA)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}